[2] Mistry initially felt she would pursue a career in dietetics, but later discovered an interest in microbiology.
After graduating from the University of Sydney, Mistry and Peter French, a cell and molecular biologist, co-founded Breast Cancer-Associated Lipid (BCAL) Diagnostics with two other found investors.
[4] Mistry’s insight into the potential of fatty acids in the blood stream, to indicate the presence of breast cancer, led to the filing of an international patent and was the basis for the formation of BCAL Diagnostics in 2010.
As Chief Scientist she had to arm herself with more than just scientific skills to successfully navigate the membrane between academia and industry.
[citation needed] In 2019, Mistry became the Head of Medtech and Biotech at deep tech incubator Cicada Innovations where she went on to support the medical innovation ecosystem through a number of startup and scaleup programs,[5] providing mentorship and coaching for researchers, entrepreneurs and founding teams looking to commercialise their impactful technologies.